34
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Commercialization of microfluidic point-of-care diagnostic devices.

      Lab on a Chip
      DNA, analysis, Government Regulation, HIV Infections, diagnosis, Humans, Immunoassay, Industry, Microfluidic Analytical Techniques, economics, instrumentation, methods, Point-of-Care Systems, T-Lymphocytes, cytology, metabolism

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A large part of the excitement behind microfluidics is in its potential for producing practical devices, but surprisingly few lab-on-a-chip based technologies have been successfully introduced into the market. Here, we review current work in commercializing microfluidic technologies, with a focus on point-of-care diagnostics applications. We will also identify challenges to commercialization, including lessons drawn from our experience in Claros Diagnostics. Moving forward, we discuss the need to strike a balance between achieving real-world impact with integrated devices versus design of novel single microfluidic components.

          Related collections

          Author and article information

          Comments

          Comment on this article